A preliminary study of low-dose angiotensin 1-7 plus the pineal hormone melatonin in the treatment of human systemic diseases other than cancer and autoimmune pathologies

Abstract: The recent advances of the psychoneuroimmunology have demonstrated the existence of a physiological anti-inflammatory antitumor neuroendocrine axis, mainly constituted by the pineal gland through its indole hormone melatonin (MLT) and the ACE2-angiotensin 1-7 (Ang 1-7) system. Moreover,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lissoni, Paolo, Porta, Enrica, Rovelli, Franco, Messina, Giusy, Lissoni, Arianna, Porro, Giorgio, Porro, Davide, Di Fede, Giuseppe, Monzon, Alejandra, Sassola, Andrea, Cardinali, Daniel Pedro
Formato:	Artículo
Lenguaje:	Inglés
Publicado:	Sryahwa 2022
Materias:	ANGIOTENSINA 1-7 ENZIMAS ENFERMEDADES CEREBROVASCULARES ENFERMEDADES NEURODEGENERATIVAS GLANDULA PINEAL SINDROME METABOLICO CARDIOPATIAS
Acceso en línea:	https://repositorio.uca.edu.ar/handle/123456789/13684
Aporte de:	Repositorio Institucional de la Universidad Católica Argentina (UCA) de Universidad Católica Argentina

Ejemplares similares

A randomized study of high-dose pineal hormone melatonin alone versus high-dose melatonin plus low-dose angiotensin-(1-7) in untreatable advanced cancer patients
por: Lissoni, Paolo, et al.
Publicado: (2022)

Contribution of TRPC channels in neuronal excitotoxicity associated with neurodegenerative disease and ischemic stroke
por: Jeon, Jaepyo, et al.
Publicado: (2021)

Contribution of TRPC channels in neuronal excitotoxicity associated with neurodegenerative disease and ischemic stroke
por: Jeon, Jaepyo, et al.
Publicado: (2021)

A phase II study of the pineal hormones melatonin and 5-methoxytryptamine plus cannabidiol in association with angiotensin 1-7 in the treatment of advanced solid tumour patients eligible for the only best supportive care
por: Lissoni, Paolo, et al.
Publicado: (2022)

The renin–angiotensin system modulates dopaminergic neurotransmission : A new player on the scene
por: Kobiec, Tamara, et al.
Publicado: (2021)

Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s disease
por: Pérez Lloret, Santiago, et al.
Publicado: (2021)

Melatonin as a chronobiotic and cytoprotective agent in Parkinson’s disease
por: Pérez Lloret, Santiago, et al.
Publicado: (2021)

Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression : an exploratory study in the PPMI database
por: Udovin, Lucas Daniel, et al.
Publicado: (2021)

Effects of angiotensin type 1 receptor antagonists on Parkinson's disease progression : an exploratory study in the PPMI database
por: Udovin, Lucas Daniel, et al.
Publicado: (2021)

Journal of pineal research
Publicado: (1984)

An open‐label, non‐randomized, drug‐repurposing study to explore the clinical effects of Angiotensin II Type 1 (AT1) receptor antagonists on anxiety and depression in Parkinson's Disease
por: Bordet, Sofía, et al.
Publicado: (2025)

Angiotensin converting enzyme inhibitors : mechanisms of action and clinical implications /
Publicado: (1981)

Neurodegeneraci�on y Alzh�eimer : avances tecnol�ogicos y de investigaci�on para la prevenci�on y el tratamiento /
por: Navarro Cuartiellas, Arcadi
Publicado: (2024)

Terap�eutica de la enfermedad vascular cerebral
por: Barinagarrementeria Aldatz, Fernando
Publicado: (2011)

El ictus en la mujer
por: G�allego, J.
Publicado: (2006)

Angiotensin-converting enzyme 2: angel or evil?
por: Gironacci, Mariela M.
Publicado: (2021)

On the diagnosis of pain in Parkinson disease : a mechanism-based approach
por: Mylius, Veit, et al.
Publicado: (2023)

Metodología desarrollada para mejorar la calidad de vida de las personas con enfermedad de Parkinson (EP) mediante la aplicación de los principios teóricos del fenómeno paradojal en el Taller de Parkinson (TDP)
por: Dillon, José Luis, et al.
Publicado: (2010)

Rethinking Melatonin Dosing: Safety and Efficacy at Higher-than-Usual Levels in Aged Patients with Sleep Disturbances and Comorbidities
por: Valiensi, Stella M., et al.
Publicado: (2025)

The Parkinson`s disease pain classification system (PDPCS): results from an international mechanism-based classification approach
por: Mylius, Veit, et al.
Publicado: (2021)

The Parkinson`s disease pain classification system (PDPCS): results from an international mechanism-based classification approach
por: Mylius, Veit, et al.
Publicado: (2021)

El aporte de la telemedicina en la prevención y en el tratamiento de las enfermedades neurodegenerativas.
por: Lareng, Louis

The positive inotropic effect of angiotensin II : Role of endothelin-1 and reactive oxygen species
por: Cingolani, Horacio Eugenio, et al.
Publicado: (2006)

Asociación entre enfermedad periodontal y la cardiopatía isquémica
por: Lewin, Pablo Gastón
Publicado: (2006)

Angiotensin 1-7 as the possible universal panacea of human systemic diseases And potentially the best anti-aging molecule of human body
por: Lissoni, Paolo, et al.
Publicado: (2022)

The renin angiotensin system in the central nervous system
por: Choi, Marcelo R., et al.
Publicado: (2011)

Alteraciones en la proteína precursora de amiloide β (APP) inducidas por los depósitos de amiloide β
por: Heredia, María Florencia
Publicado: (2025)

Effect of naloxone on the nocturnal rise of rat pineal melatonin content
por: Lowenstein, P.R., et al.

Effect of naloxone on the nocturnal rise of rat pineal melatonin content
Publicado: (1984)

Are melatonin doses employed clinically adequate for melatonin-induced cytoprotection?
por: Cardinali, Daniel Pedro
Publicado: (2019)

Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
por: Herrera, María I., et al.
Publicado: (2019)

Neuroprotection targeting protein misfolding on chronic cerebral hypoperfusion in the context of metabolic syndrome
por: Herrera, María Inés, et al.
Publicado: (2019)

Worsening of memory deficit induced by energy-dense diet in a rat model of early-Alzheimer's disease is associated to neurotoxic Aβ species and independent of neuroinflammation
por: Martino Adami, Pamela V., et al.
Publicado: (2019)

Recidiva de infarto cerebral
por: Martos Ben�itez, Frank Daniel
Publicado: (2009)

Terapia génica anti-inflamatoria en el abordaje de la neurodegeneración dopaminérgica motora
por: Falomir Lockhart, Eugenia
Publicado: (2020)

Lucha médico-social contra las cardiopatías reumáticas
por: Zabala, Pedro Raúl
Publicado: (1948)

Circadian rhythm and neural regulation of rat pineal angiotensin converting enzyme
por: Nahmod, V.E., et al.

Circadian rhythm and neural regulation of rat pineal angiotensin converting enzyme
Publicado: (1982)

High doses of melatonin as a potential therapeutic tool for the neurologic sequels of covid-19 infection
por: Cardinali, Daniel Pedro
Publicado: (2020)

Melatonin. A mammalian pineal hormone
por: Cardinali, D.P.